Enlivex Therapeutics Announces up to $15 Million Registered Direct Offering

<div class="b2iNewsItemBodyDiv"><link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><ul type="disc"><li><em>Single healthcare-focused institutional investor </em></li><li><em>$5 million upfront with up to an additional $10 million of gross proceeds upon the exercise in full of clinical milestone-linked warrants</em></li></ul> <p align="justify">Nes-Ziona, Israel, May 28, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV,...